Market Insights Consumer OTC Pharmaceuticals

Wound Care - Poland

Poland

Revenue in the Wound Care market amounts to €38.08m in 2024. The market is expected to grow annually by 0.05% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€965m in 2024).
In relation to total population figures, per person revenues of €0.95 are generated in 2024.

Key regions: United States, Indonesia, Germany, Europe, United Kingdom

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Wound Care market in Poland has been experiencing steady growth in recent years, driven by customer preferences for advanced wound care products and an increasing elderly population. Customer preferences in the Wound Care market in Poland have shifted towards advanced wound care products, such as foam dressings, hydrocolloid dressings, and alginate dressings.

These products offer better wound healing outcomes and are more convenient to use compared to traditional dressings. Additionally, there is a growing demand for wound care products with antimicrobial properties, as healthcare professionals and patients are increasingly concerned about the risk of infection. The market is also benefiting from the increasing elderly population in Poland.

As people age, they are more prone to chronic wounds, such as pressure ulcers and diabetic foot ulcers. This has led to a higher demand for wound care products and services. Furthermore, the elderly population in Poland is expected to continue growing in the coming years, which will further drive the demand for wound care products.

In addition to customer preferences and demographics, there are several local special circumstances that are shaping the Wound Care market in Poland. One such circumstance is the high prevalence of diabetes in the country. Poland has one of the highest rates of diabetes in Europe, which increases the risk of developing diabetic foot ulcers.

This has created a significant demand for wound care products and services specifically tailored to diabetic patients. Another local special circumstance is the presence of a well-developed healthcare system in Poland. The country has a network of hospitals, clinics, and healthcare professionals that provide specialized wound care services.

This infrastructure supports the growth of the Wound Care market by ensuring access to care and facilitating the adoption of advanced wound care products. Underlying macroeconomic factors also play a role in the development of the Wound Care market in Poland. The country has been experiencing steady economic growth, which has led to increased healthcare spending.

This has enabled healthcare facilities to invest in advanced wound care products and services, driving market growth. Additionally, the government has implemented healthcare reforms aimed at improving the quality and accessibility of healthcare services, including wound care. These reforms have further stimulated the demand for wound care products and services.

In conclusion, the Wound Care market in Poland is growing due to customer preferences for advanced wound care products, an increasing elderly population, local special circumstances such as the high prevalence of diabetes, a well-developed healthcare system, and underlying macroeconomic factors such as economic growth and healthcare reforms.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.